Association of the gallbladder or biliary diseases with dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes: a meta-analysis of randomized controlled trials

BACKGROUND: Previous studies have shown inconsistent conclusions regarding the association between incretin-based therapies and the risk of developing gallbladder or biliary diseases. We conducted a meta-analysis to evaluate the risk of gallbladder or biliary diseases associated with dipeptidyl pept...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Meng, Yang, Zheng, Chen, Chongxin, Lv, Yuhuan, Xiang, Linyu, Zhao, Subei, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585736/
https://www.ncbi.nlm.nih.gov/pubmed/36271423
http://dx.doi.org/10.1186/s13098-022-00924-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585736/
https://www.ncbi.nlm.nih.gov/pubmed/36271423
http://dx.doi.org/10.1186/s13098-022-00924-8

Ejemplares similares